Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xylopia Formulation is a pharmaceutical company based in Ahmedabad, India, specializing in formulation development and contract manufacturing services (CDMO). The company provides end-to-end solutions for the development of generic drug products, ranging from pre-formulation and analytical development to commercial-scale production. Their state-of-the-art manufacturing facility is designed to comply with international regulatory standards and is capable of producing various dosage forms, including oral solids, liquids, and semi-solids. Xylopia focuses on optimizing drug delivery systems and enhancing the stability and efficacy of pharmaceutical products for its global partners. The firm serves a diverse range of therapeutic areas, including gastroenterology, cardiovascular health, and general medicine. By leveraging advanced technology and technical expertise, Xylopia Formulation aims to deliver high-quality, cost-effective healthcare solutions to the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xylopia Formulation Lab.